Griffith College Dublin MSc in Pharmaceutical Business and Technology

What is Griffith College Dublin MSc in Pharmaceutical Business and Technology, and what does it cost?

Griffith runs this one with Innopharma Education rather than alone, teaching four days a week in Dublin while QQI awards the degree. Tuition is EUR 17,500 against the EUR 16,000 its three siblings charge, which puts the full year at about INR 50.31 lakh.

It is a business and technology master’s about how medicines get made, regulated and sold, not a pharmacy qualification. That distinction is the most important thing on this page for an Indian B.Pharm graduate, who is squarely inside the entry rule and squarely outside any effect on being licensed to practise, in Ireland or in India.

How much does Pharmaceutical Business MSc cost for an Indian student?

The upper twelve-month plan is EUR 45,715, about INR 50.31 lakh. It combines EUR 17,500 tuition, EUR 1,105 in currently listed compulsory charges, the upper EUR 27,050 Dublin postgraduate living estimate and a EUR 60 single-entry visa. Euro figures are the stable budgeting basis because exchange rates don’t stay fixed. The immigration floor proves funds, not cost.

The EUR 10,000 immigration finance floor is evidence for a visa file, not a realistic estimate of one year in Dublin. Converted at EUR 1 = INR 110.0485, the ECB reference rate for 1 September 2026. Payment-provider rates differ. A refundable housing deposit and any instalment charge affect cash flow but are not treated as consumed programme cost.

Griffith’s central schedule lists EUR 17,500 tuition and EUR 1,105 in compulsory charges for this programme type. The live fee pages aren’t fully consistent on every label. The final amount must come from the offer and invoice.

The current schedule describes a EUR 1,500 Innopharma master’s bursary. If it is written into the offer, tuition plus listed charges is EUR 17,105. The separate Global Excellence and Academic Merit rules do not cover this exact programme in the same way as the standard master’s routes.

The page uses Trinity’s upper Dublin postgraduate allowance because neither Griffith nor Innopharma publishes a complete twelve-month budget. Any timetable-related travel or equipment cost beyond ordinary living expenses remains unpublished.

Payment language differs across Griffith documents, so request a written breakdown of the offer payment, non-refundable amount, visa-support payment and applicable refund terms. The EUR 6,000 immigration payment rule and the College’s contractual deposit are separate.

Permitted student work cannot make an underfunded pharmaceutical plan safe. Working hours are restricted, shifts are not guaranteed and an international learner may also need to protect attendance and dissertation time.

Can an Indian applicant meet the Pharmaceutical Business MSc entry rules?

The rule is a 2.2 honours degree at NFQ Level 8 in Science, Engineering or Quality, or a related discipline, per the course page. It is a subject rule rather than a pharmacy rule, so a B.Pharm, a B.Sc in chemistry or biotech and an engineering degree all sit inside it, and a commerce or arts degree does not.

Send the transcript with subject names. The entry decision is about whether your degree is a science, engineering or quality degree, and that is a question about modules rather than about the title on the certificate.

The September 2026 intake starts this month and the only deadline anyone publishes is Innopharma’s “late August”, so February 2027 in Dublin is the realistic target. Ask which campus and which mode the offer is for, because the blended and Cork options are not usable on an Irish study permission.

What most applicants miss

1. It costs more than its siblings and gets less scholarship

   This programme sits in the Tuition Fees Exceptions block of Griffith’s non-EU schedule at EUR 17,500, against EUR 16,000 for the MBA, the MSc in Accounting and Finance Management and the MSc in Big Data. The gap widens twice more. The bursary for an Innopharma Masters is EUR 1,500 where a standard masters gets EUR 2,000, and the schedule states

   “Innopharma Masters are not eligible for the Academic Merit Scholarship (AMS).”Griffith College non-EU postgraduate fee schedule

   A strong academic record that would be worth up to EUR 2,000 on a sibling course is worth nothing here. Compare the net figure, not the headline.

2. Your application goes to Innopharma, not to Griffith admissions

   The course page routes enquiries to the Innopharma Education team rather than to Griffith’s admissions office, and Innopharma runs its own enquiry, callback and emailed-form process. Applying through Griffith’s general online form is the slower path. It also means the people answering your questions about entry and start dates work for the delivery partner, so get anything that matters, especially the start date and the fee, confirmed in writing with the Griffith award named on it.

3. There is no laboratory work in the ninety credits

   The taught modules cover pharmaceutical quality systems, the regulatory landscape, technology transfer, operational excellence and clinical research management, then a 30-credit dissertation. None of them is a lab module. Griffith and Innopharma do market pilot-plant, GMP and contamination-control facilities at Sandyford, but those belong to a different award, the MSc in Pharmaceutical Quality Systems Validation and Technology, which costs the same. If hands-on GMP work is what you want, you want the other one.

How should an Indian applicant apply for Pharmaceutical Business MSc?

Griffith displays September 2026 and February 2027 but publishes no single final programme deadline. The timeline uses 31 October 2026 as an Nbyula complete-file target for February 2027, not a Griffith deadline. Visa-required applicants are advised to apply at least three months before the programme begins. The award sits at Level 9 on the National Framework of Qualifications.

Duplicate applications should be avoided. Griffith provides a direct international form, while Innopharma begins with an enquiry and emailed application. The application team must identify who owns the full-time international file. The passport, degree, transcripts, mathematics evidence, English result and requested supporting material then belong in that route.

The allowances are Nbyula planning estimates, not processing times published by Griffith College Dublin.

Innopharma says screening can take up to one week in busy periods. Its material also refers to a late-August point for September without publishing an exact date, while no final February closing date was found. Current availability must be established before either listing is relied on.

The first review should cover degree level, pharmaceutical relevance and the Irish mathematics condition. A portal submission cannot answer how an Indian school result maps to O6 or H7, so obtain that decision separately in writing.

A successful admission file still needs the full-time Dublin dates, tuition payment, finance evidence, insurance and visa documents. Immigration requires at least EUR 6,000 of tuition to be paid before applying where course fees exceed EUR 6,000.

Request the intake’s teaching schedule, deposit date, registration deadline and late-arrival policy from the team handling the application. These details matter because current full-time and part-time duration wording is inconsistent.

What career evidence and Irish work rights follow Pharmaceutical Business MSc?

Ireland is genuinely a pharmaceutical manufacturing centre and this degree genuinely points at it. What doesn’t exist is any published outcome for this specific course, and the employment figure applicants are most often shown belongs to something far broader. For licensure, the PSI route is a separate matter entirely.

Named employer lists on the faculty pages cover every Innopharma course across three industries. They are not destinations for this programme.

The roles this points at are real and they are not clinical: production and supervisory management, quality and regulatory affairs, supply chain, project management, process improvement and clinical research coordination. Those are the jobs Ireland’s pharmaceutical plants actually advertise, and a science graduate with a business master’s is a sensible shape for them.

What the degree does not do is move you a step closer to being a pharmacist. If you already hold a B.Pharm and can register in India, this adds management credentials on top of that registration. It does not create one, extend one, or shorten anyone’s route to one.

Who should apply for Pharmaceutical Business MSc, and who should not?

This is for a science or engineering graduate who wants to move off the bench and into the plant, the quality function or the regulatory side. It’s a poor fit for anyone whose plan involves the word pharmacist, in Ireland or India, and the fee schedule prices it above its siblings.

The clean test is what you want to be doing in three years. If the answer involves dispensing, prescribing or a pharmacy licence, this is the wrong award and no amount of pharmaceutical content in the title changes that.

If the answer involves running a process, signing off a batch or owning a regulatory submission, this is a reasonable one-year route into it, and the price premium over the siblings is the thing to negotiate rather than the thing to ignore.

What does the 90 ECTS Pharmaceutical Business MSc contain?

Seven taught modules over two semesters make up 60 credits, then a 30 credit dissertation, one third of the award. The teaching is management and regulation rather than laboratory work. Griffith publishes credits by semester block rather than per module, so no per-module figure is quoted here.

• The full master's requires 90 ECTS
• The 30 ECTS capstone is not a published placement

Griffith and Innopharma jointly deliver a sector-focused curriculum spanning manufacturing, quality systems, regulation, clinical research, technology transfer, leadership and operational improvement. It is aimed at pharmaceutical business and operations rather than pharmacist registration or laboratory research training.

The final 30 ECTS stage is a dissertation. No internship, paid placement or separately named industry-project option is published. Topic and supervisor allocation are unpublished, especially for a project tied to a specific pharmaceutical function.

The full-time international evidence supports a 12-month Dublin route. Part-time duration and some attendance descriptions conflict across current Innopharma material, so the offer must state the teaching days, campus expectations and dissertation period for the selected intake.

Should an Indian applicant shortlist Pharmaceutical Business MSc?

Shortlist this if you’re a science or engineering graduate heading for pharmaceutical manufacturing, quality or regulatory work. Rule it out if any part of the plan needs a pharmacy licence, because this award has no bearing on registration in either country.

Ninety credits over twelve months, four days a week on campus in Dublin, split sixty taught and thirty for the dissertation. Griffith and Innopharma teach it together and QQI awards it at Level 9. It is a management and regulation degree about an industry, and nothing in it is laboratory work.

Three costs are easy to miss. The fee is EUR 17,500 rather than the EUR 16,000 its siblings charge, the bursary is smaller, and the Academic Merit Scholarship is closed to this programme entirely. Griffith's published schedule is also labelled for the September 2025 intake onwards, so confirm the February 2027 figure in writing before you plan around it.

Sources

These sources support the programme, admission, cost, experience and immigration information used on this page.

Sources checked on September 1, 2026. Current intake information follows. September 2026 and February 2027 are displayed; the final application deadline is unpublished.